Table 4 Comparison between patient’s satisfactions from joint function after core decompression with investigated variables
Joint satisfaction | Uni-variable logistic regression | Multivariable logistic regression | ||
|---|---|---|---|---|
Odds ratio (CI 95%) | P value | Odds ratio (CI 95%) | P value | |
Male gender | 0.000 (0.000–0) | 0.999 |  |  |
Bilateral Hip osteonecrosis | 0.585 (0.098–3.485) | 0.556 | ||
Abnormal C3, C4 levels | 1346E+12 ( 0.000–0) | 0.999 | ||
Abnormal aPL levels | 3.250 (0.586–18.034) | 0.178 | ||
SLE relapse | 2.000 (0.524–7.630) | 0.310 | ||
Kidney damage | 2.500 (0.666–9.385) | 0.175 | ||
Neuro damage | 1346E+12 ( 0.000–0) | 0.999 | ||
Azathioprine | 2.364 (0.619–9.023) | 0.209 | ||
HCQ | 0.143 (0.016–1.288) | 0.083 | 0.239 (0.023–2.422) | 0.226 |
Methotrexate | 1.333 (0.287–6.387) | 0.719 |  |  |
Mycophenolate mofetil | 0.800 (0.152–4.204) | 0.792 | ||
Aspirin | 0.564 (0.152–2.087) | 0.391 | ||
Statins | 0.724 (0.160–3.276) | 0.675 | ||
Bisphosphonate | 0.132 (0.031–0.565) | 0.006** |  | 0.02* |
Smoking (Cigarette) | 1.053 (0.212–5.232) | 0.950 |  |  |
Alcohol | 3.684 (0.386–35.140) | 0.257 | ||
Anti-ds DNA level | With independent sample T test 84.77–103.55 (IU/ml) | 0.35 |  |  |